Which hedge funds own GALT? GALECTIN THERAPEUTICS INC, Q2 2026 13F holders
5 of the hedge funds tracked by WhaleCreep disclosed a position in GALT (GALECTIN THERAPEUTICS INC) in their Q2 2026 13F filings, worth $5.4m in total. The largest holder by portfolio weight is Marshall Wace at 0.0% of its book. 1 exited: Brevan Howard Capital Management.
5tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold GALT? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Marshall Wace | Q2 2026 | 0.0% | $3.9m | 831,010 | -32% | reduced |
| Horizon Kinetics | Q2 2026 | 0.0% | $217.9k | 46,968 | -5% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $922.0k | 198,701 | -32% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $201.1k | 43,343 | -71% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $166.4k | 35,863 | -96% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $99.3k |
How has hedge fund ownership of GALT changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $5.4m |
| Q1 2026 | 6 | $7.1m |
| Q4 2025 | 1 | $214.2k |
| Q3 2025 | 2 | $561.1k |
| Q2 2025 | 2 | $136.1k |
| Q1 2025 | 2 | $81.4k |
| Q4 2024 | 1 | $69.3k |
| Q3 2024 | 1 | $141.6k |
| Q2 2024 | 1 | $121.5k |
| Q1 2024 | 1 | $128.4k |
| Q4 2023 | 1 | $89.2k |
| Q3 2023 | 1 | $107.5k |
| Q2 2023 | 1 | $80.6k |
| Q1 2023 | 1 | $117.6k |
| Q4 2022 | 1 | $29.4k |
| Q3 2022 | 1 | $42.0k |
Counts every tracked manager that disclosed GALT in that quarter's filing, including managers that have since stopped filing.